News Articles Tagged: Anxiolytic Drug

Understanding 3,3-Tetramethyleneglutarimide: A Key Pharmaceutical Intermediate

An overview of 3,3-Tetramethyleneglutarimide, its properties, applications in drug synthesis, and its importance in the pharmaceutical supply chain.

The Role of Pharmaceutical Intermediates in Developing Advanced Anxiolytic Agents

Discover how high-purity pharmaceutical intermediates, like those targeting GABA receptors, are crucial for the innovation of effective anxiolytic drugs and treatments for neurological conditions.

Exploring the Therapeutic Potential: GABA_B Receptor Agonism of 4-Amino-3-(4-fluorophenyl)butyric Acid Hydrochloride

NINGBO INNO PHARMCHEM CO.,LTD. discusses the therapeutic implications of 4-Amino-3-(4-fluorophenyl)butyric Acid Hydrochloride, focusing on its GABA_B receptor agonism.

The Science Behind Selank: Insights into its Development and Research

Explore the scientific journey of Selank peptide, from its development as a synthetic analogue of tuftsin to its ongoing research into anxiolytic and nootropic effects, as highlighted by NINGBO INNO PHARMCHEM CO.,LTD.

Selank Peptide: Applications in Pharmaceutical Research and Development

An overview of the diverse applications of Selank peptide in pharmaceutical research and development, highlighting its potential in new drug discovery and therapeutic advancements from NINGBO INNO PHARMCHEM CO.,LTD.